Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fortum January-March 2023 Interim Report: Strong start for the year in clean power generation

FORTUM CORPORATION JANUARY–MARCH 2023 INTERIM REPORT 11 MAY 2023 AT 9:00 EEST This release is a summary of Fortum’s January–March 2023 Interim Report. The complete report is attached to this release as a PDF file. It is also available on the company's website at www.fortum.com/investors January−March 2023, continuing operations · Comparable EBITDA was EUR 891 (527) million · Comparable operating profit was EUR 784 (388) million · Operating profit was EUR 855 (246) million, mainly impacted by fair values changes in non-hedge-accounted derivatives. The comparison period

Viaplay Group appoints Sandra Åberg SVP and Head of Investor Relations

Viaplay Group has appointed Sandra Åberg SVP and Head of Investor Relations. Sandra is currently Investor Relations Director at Essity in Stockholm and brings extensive experience in investor relations and finance from a broad range of international businesses. She will join Viaplay Group in September 2023 and report to Anders Jensen, Viaplay Group President and CEO.   Sandra joined Essity, a global hygiene and health company listed on Nasdaq Stockholm, in 2017. She previously spent 10 years in investor relations and treasury roles at SCA. After beginning her career at Bain & Company,

Lytix Biopharma presents first quarter 2023 results

Oslo, 11 May 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, today releases its first quarter 2023 results – New class of immunotherapy.“Lytix is fast approaching an important milestone, as we now are looking forward to completing recruitment in our ATLAS-IT-05 study this summer and deliver the first interim report from this study before the end of the year. At the same time, we are encouraged by seeing our partner Verrica Pharmaceuticals continue to make progress in their Phase II study, now running through the

Year-end Report April 2022 - March 2023

Significant sales growth, increasing profit margin and a growing pipeline January - March 2023 · Consolidated sales during the fourth quarter, January to March amounted to SEK 60.3 (203.0) million. Adjusted for non-recurring sales the revenue amounted to 53.5 (36.1) MSEK, an increase of 48%. · Gross profit amounted to SEK 28.1 (31.6) million for the quarter, an increase of 11%. · EBIT amounted to SEK 6.1 (11.9) million, a decrease of 49%. The operating margin was 10% (6%). · Earnings per share were SEK 0:14 (0:22) for the quarter. · Cash flow from operating activities

Neogap expands team with software expert to drive cancer immunotherapy innovation

Swedish biotech company Neogap Therapeutics has recruited bioinformatics and software development expert Alejandro Fernandez Woodbridge to strengthen the development of its software platform, PIOR®, for personalised cancer immunotherapy.Alejandro Fernandez Woodbridge holds a PhD in bioinformatics of 3D chromatin architecture and epigenetics from Karolinska Institutet and has extensive experience in transcriptomics and proteomics from his postdoc at SciLife lab. Prior to joining Neogap, Alejandro co-founded two successful consultancy companies specialising in bioinformatics and machine

Milestone reached in Germany

FIRST QUARTER 2023 · Revenue increased 39% to SEK 631m (455) · Operating profit increased 42% to SEK -14m (-25) · Operating margin increased to -2.2% (-5.4) · Result for the period decreased by 89% to SEK 7m (63) · Earnings per share from continuing operations1 amounted to SEK 0.46 (-2.13) · Cash flows from operating activities amounted to SEK -126m (-16)      []SEK m (or as stated) 2023 2022 % FY2022 Q1 Q1Revenue 631 455 39% 1,973Gross profit 85 53 59%

Pagero publishes interim report for Q1 2023: Strong start of the year with accelerating organic growth

Pagero Group AB (publ) publishes interim report for the period January-March 2023“The stars that support our business are aligned and we continue to see a growing need in all our markets. During the quarter, we grew net sales by 32% and we had an increase in Annualized Recurring Revenue (ARR) of 33%. We also see increasing efficiency in our direct sales and were pleased to receive our largest order to date of EUR 4.2 million during the quarter”, says Bengt Nilsson, CEO at Pagero.  First quarter of 2023 · Net sales amounted to SEK 179.8 million (136.7), which is an increase of 32% (

Wihlborgs signs agreement with Region Skåne for 17,200 m² in the Malmö area

Wihlborgs is set to construct a warehouse for Region Skåne in the Malmö area with occupancy in early 2025. The lease term is 20 years.The new property will be used for logistics and to house inventory. The building of nearly 17,200 m² will be constructed to a high technical standard and be environmentally certified.   The total investment will amount to SEK 300 million. “We are delighted to be building a modern, fit-for-purpose and sustainable facility for Region Skåne and look forward to a long-term partnership in an area with a critical function for society,” says Ulrika Hallengren,

RugVista Group AB (publ) – publishes Interim Report for January – March 2023

Good profitability and progress on strategic initiatives First quarter 2023 · The net revenue was MSEK 180.3 (186.0), corresponding to a decrease of -3.1% (-9.1%) · The organic net revenue growth was -8.1% (-12.3%) · The gross margin increased slightly to 62.6% (62.3%) · The EBIT improved to MSEK 25.7 (21.5) and the EBIT-margin also improved to 14.2% (11.6%) · The profit for the period increased to MSEK 20.3 (16.8) · The inventory value as a percentage of LTM net revenue amounted to 26.0% (21.6%) · The net cash at the end of the period was MSEK 116.1 (162.7) ·

Sciety and Sciety Venture Partners invest EUR 5.3 million in Capitainer

Sciety and Sciety Venture Partners recently completed an investment of EUR 5.3 million in Capitainer, a Swedish medtech company that has developed a unique platform for self-sampling of blood, facilitating remote healthcare solutions and personalized medicine. The capital will be used for sales & marketing and expanding production capacity to establish Capitainer as a leading supplier of self-sampling solutions with market-leading clinical accuracy.Capitainer's platform allows people to collect blood samples from their fingertips, anytime and anywhere, and send the samples by regular mail

Checkin.com Group Quarterly Report Q1 2023

Checkin.com Group (STO:CHECK) reports increased profitability and a growth in revenue of 19% during the first quarter of 2023. The report in brief: (Q1 2023 vs Q1 2022): · Net revenue increased to KSEK 18,839 (15,794) which corresponds to a growth of 19 (107)%, of which 16 (78)% was organic. · Gross profit for the period amounted to KSEK 15,549 (13,604) with a margin of 83 (86)%. · EBITDA for the period amounted to KSEK 2,769 (-705) with a margin of 15 (-4)%. · Cash flow from operating activities amounted to KSEK 2,578 (-835). · Net Revenue Retention LTM amounted to 108

Strong profitability despite macroeconomic uncertainty

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, reports a decrease in net sales of 3 percent combined with an adjusted EBITDA of SEK 150 million and a EBITDA margin of 39 percent in the first quarter of 2023.“The demand and need for our services continues to grow globally. Our user base continued to increase during the quarter; growth was slightly weaker at the beginning of the year but increased toward the end of the quarter. The stronger growth has continued in the second quarter and in April we reached a new milestone when we passed 350

Anora’s Interim Report January–March 2023: Solid sales growth, EBITDA declined due to currency impacts, increased input costs and higher operating expenses

Anora Group Plc   Stock Exchange Release  11 May 2023 at 8:30 am EEST  Anora’s Interim Report January–March 2023: Solid sales growth, EBITDA declined due to currency impacts, increased input costs and higher operating expenses  This release is a summary of Anora Group Plc's Interim Report January–March 2023. The complete report is attached to this release and is also available on the company website at: www.anora.com/en/investors    Q1 2023 in brief  ·Net sales were EUR 159.5 (133.4) million. Net sales were positively impacted by the acquisition on Globus Wine in July 2022,

Capitainer secures 5.7 MUSD to advance self-sampling technology and accelerate growth

Swedish medtech company Capitainer has raised just over 5.7 million USD to expand and commercialise its unique self-sampling technology for remote healthcare solutions and personalised medicine. The funding will be used to increase production capacity, develop new products, and intensify sales and marketing efforts. The investment round was led by Sciety and the network Sciety Venture Partners.Capitainer's self-sampling technology enables patients to take precise blood samples using a special card, which is then sent for analysis by standard post without the need for refrigeration or

Fazer Aito renews its brand and aspires growth also in the international oat drink markets

The significant brand renewal can be seen not only in the Fazer Aito packaging design but also in the recipes and in the expansion of the product range. The new products have been developed according to the consumers’ wishes, and the colourful and fresh packaging design will brighten up the oat drink, cooking product and gurt shelves. The share of plant-based products in Fazer’s offering is already 48 percent, and now the company is aiming to grow its entire plant-based product range and market share even more in Finland and internationally.This spring, Fazer Aito is being renewed in many

Students positive towards AI, but uncertain about what counts as cheating

Students in Sweden are positive towards AI tools such as ChatGPT in education, but 62 percent believe that using chatbots during exams is cheating. However, where the boundary for cheating lies is highly unclear. This is shown in a survey from Chalmers University of Technology, which is the first large-scale study in Europe to investigate students' attitudes towards artificial intelligence in higher education.“I am afraid of AI and what it could mean for the future.”“Don't worry so much! Keep up with the development and adapt your teaching for the future.”“ChatGPT and

Green Landscaping Group (publ) Interim report January-March 2023

11 May 2023, 07:00 CEST January-March 2023   · Net sales amounted to SEK 1,250 (876) million. · Growth was 43 percent, of which organic growth amounted to 12 percent. · EBITA increased by 41 percent to SEK 86 (61) million. · EBITA margin amounted to SEK 6.9 (7.0) percent. · Cash flow from operating activities amounted to SEK 221 (148) million. · Basic earnings per share were SEK 0.63 (0.27). · Diluted earnings per share were SEK 0.63 (0.27).   * Earnings per share was positively affected by currency revaluations with net SEK 21 (–6) million.   CEO

Cloudberry Clean Energy ASA | First quarter 2023 report

Oslo, Norway, 11 May 2023: Cloudberry Clean Energy ASA (“Cloudberry” or the “Company”) reports a ten time increase on proportionate EBITDA on the back of tripling of production in the first quarter 2023 compared to the same quarter last year.· Financial highlights · Strong growth in revenue and profitability over the quarter. Consolidated and proportionate revenue of NOK 68m (30m) and NOK 115m (38m) in the first quarter respectively (same quarter last year) · Consolidated and proportionate EBITDA of NOK 20m (12m) and NOK 48m (5m) in the first quarter respectively · The

Interim Report Q1, 2023: Increased number of stores and a new proposed dividend

Speqta AB (publ) Interim Report for the period January 1–March 31, 2023 is published and available on: https://speqta.com/en/investors/financial-reports During the fourth quarter of 2021, Eone Oy (Rahalaitos) was divested and during the second quarter of 2022, Mytaste Food & Beverage AB (Vinklubben) and the business in Speqta Affilijet AB together with Leads on Top AB (Affilijet) were also divested. This means that the income statements for 2022, in the report, have been recalculated in accordance with current Accounting Principles and therefore exclude divested operations

poLight ASA – First design-win for a smartphone project led to all-time high quarterly revenue

KEY EVENTS in the Quarter *             First smartphone design-win and mass production purchase order worth NOK 2.9 million announced during the quarter. •             Augmented reality (AR) cases continued to mature. Both Magic Leap 2 and LLVision use TLens®  for their latest enterprise AR glasses. •             Follow-on order worth approximately NOK 650,000 received for TLens® to be used in a machine vision device, first announced on 18 May 2021. •             Quarterly all-time high revenue of NOK 7.1 million. •             The rights issue was oversubscribed by

Veidekke: Q1 2023 results

Veidekke achieved revenues of NOK 9.5 billion in Q1. A dispute with the Norwegian Public Roads Administration was settled with a negative impact on earnings. The underlying loss was NOK -37 million before tax. The group’s order book totalled NOK 43.1 billion at quarter-end. The loss per share was NOK -0.9.“The underlying performance of the group’s operations is strong, in a first quarter that displayed the customary seasonal downturn,” says Group CEO Jimmy Bengtsson. “We have reached an agreement with the National Public Roads Administration in the dispute over E39 Svegatjørn–Rådal, a

Hexagon Composites ASA: First quarter 2023

11 May 2023: Hexagon (excluding Hexagon Purus) reported revenues of NOK 1 130 (913) million, representing 24% growth compared to the same quarter last year driven by higher volumes, improved pricing as well as favorable FX translation effects. Operating profit before depreciation (EBITDA) totaled NOK 83 (84) million for the quarter. In the first quarter of 2023, Hexagon Purus revenues grew 53% year-over-year to NOK 244 (159) million with an EBITDA of NOK -112 (-93) million. In March, Hexagon Purus raised gross NOK 500 in new equity and NOK 800 in a convertible bond. Following the capital

Smartoptics Group AS (SMOP) – Q1 2023: Continued strong growth and increased margins

Oslo, May 11, 2023 - Smartoptics Group AS (OSE: SMOP) today reported revenues of USD 14.1 million in the first quarter of 2023, up 18.8 percent from the corresponding period in 2022 (USD 11.8 million), and an EBITDA margin of 18.5 percent, up from 15.2 percent in the first quarter 2022. EBIT margin was 15.5 percent compared to 11.8 percent same period last year.“It is great to conclude that the strong development from 2022 continues in 2023, as expected. The market remains strong, driven by the ever-growing demand for higher bandwidth and network capacity,” said Magnus Grenfeldt, CEO of

Lundbeck and Otsuka announce U.S. Food and Drug Administration (FDA) approval of sNDA for Rexulti® (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer’s Disease

· Rexulti is the first and only pharmacological treatment approved in the U.S. for agitation associated with dementia due to Alzheimer’s disease Valby, Denmark, May 11, 2023 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of Rexulti® (brexpiprazole) for use in the treatment of agitation associated with dementia due to Alzheimer’s disease. This approval makes Rexulti the first and only pharmacological treatment approved in the U.S. for agitation

There are no items matching the current filter
There are no more items matching the current filter
Back to top